The dual functions of the extreme N-terminus of TDP-43 in regulating its biological activity and inclusion formation

Human Molecular Genetics

Volumn 22, Issue 15, 2013, Pages 3112-3122

  Zhang, Yong Jie ^a   Caulfield, Thomas ^a   Xu, Ya Fei ^a   Gendron, Tania F ^a   Hubbard, Jaime ^a   Stetler, Caroline ^a   Sasaguri, Hiroki ^a   Whitelaw, Ena C ^a   Cai, Shuyi ^a   Lee, Wing Cheung ^a   Petrucelli, Leonard ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; TAR DNA BINDING PROTEIN; THREONINE; VALINE;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL CULTURE; DIMERIZATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STABILITY;

AMYOTROPHIC LATERAL SCLEROSIS; DNA-BINDING PROTEINS; FRONTOTEMPORAL DEMENTIA; HUMANS; INCLUSION BODIES; MODELS, ANATOMIC; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; RNA SPLICING;

EID: 84880323707     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt166     Document Type: Article

References (44)

1. Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y. et al. (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun., 351, 602-611.
2. Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., Chou, T.T., Bruce, J., Schuck, T., Grossman, M., Clark, C.M. et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314, 130-133.
3. Buratti, E. and Baralle, F.E. (2008) Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front Biosci., 13, 867-878.
4. Winton, M.J., Igaz, L.M., Wong, M.M., Kwong, L.K., Trojanowski, J.Q. and Lee, V.M. (2008) Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem., 283, 13302-13309.
5. Ayala, Y.M., Pantano, S., D'Ambrogio, A., Buratti, E., Brindisi, A., Marchetti, C., Romano, M. and Baralle, F.E. (2005) Human, Drosophila, and C. elegans TDP43: nucleic acid binding properties and splicing regulatory function. J. Mol. Biol., 348, 575-588.
6. Buratti, E. and Baralle, F.E. (2001) Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J. Biol. Chem., 276, 36337-36343.
7. Buratti, E., Brindisi, A., Giombi, M., Tisminetzky, S., Ayala, Y.M. and Baralle, F.E. (2005) TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J. Biol. Chem., 280, 37572-37584.
8. Gitcho, M.A., Baloh, R.H., Chakraverty, S., Mayo, K., Norton, J.B., Levitch, D., Hatanpaa, K.J., White, C.L. 3rd, Bigio, E.H., Caselli, R. et al. (2008) TDP-43 A315T mutation in familial motor neuron disease. Ann. Neurol., 63, 535-538.
9. Kabashi, E., Valdmanis, P.N., Dion, P., Spiegelman, D., McConkey, B.J., Vande Velde, C., Bouchard, J.P., Lacomblez, L., Pochigaeva, K., Salachas, F. et al. (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet., 40, 572-574.
10. Rutherford, N.J., Zhang, Y.J., Baker, M., Gass, J.M., Finch, N.A., Xu, Y.F., Stewart, H., Kelley, B.J., Kuntz, K., Crook, R.J. et al. (2008) Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet., 4, e1000193.
11. Sreedharan, J., Blair, I.P., Tripathi, V.B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J.C., Williams, K.L., Buratti, E. et al. (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science, 319, 1668-1672.
12. Yokoseki, A., Shiga, A., Tan, C.F., Tagawa, A., Kaneko, H., Koyama, A., Eguchi, H., Tsujino, A., Ikeuchi, T., Kakita, A. et al. (2008) TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann. Neurol., 63, 538-542.
13. Igaz, L.M., Kwong, L.K., Chen-Plotkin, A., Winton, M.J., Unger, T.L., Xu, Y., Neumann, M., Trojanowski, J.Q. and Lee, V.M. (2009) Expression Of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 proteinopathies. J. Biol. Chem., 284, 8516-8524.
14. Zhang, Y.J., Xu, Y.F., Cook, C., Gendron, T.F., Roettges, P., Link, C.D., Lin, W.L., Tong, J., Castanedes-Casey, M., Ash, P. et al. (2009) Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl. Acad. Sci. U S A., 106, 7607-7612.
15. Nonaka, T., Kametani, F., Arai, T., Akiyama, H. and Hasegawa, M. (2009) Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum. Mol. Genet., 18, 3353-3364.
16. Fuentealba, R.A., Udan, M., Bell, S., Wegorzewska, I., Shao, J., Diamond, M.I., Weihl, C.C. and Baloh, R.H. (2010) Interaction with polyglutamine aggregates reveals a Q/N-rich domain in TDP-43. J. Biol. Chem., 285, 26304-26314.
17. Budini, M., Buratti, E., Stuani, C., Guarnaccia, C., Romano, V., De Conti, L. and Baralle, F.E. (2012) Cellular model of TAR DNA-binding protein 43 (TDP-43) aggregation based on its C-terminal Gln/Asn-rich region. J. Biol. Chem., 287, 7512-7525.
18. Ling, S.C., Albuquerque, C.P., Han, J.S., Lagier-Tourenne, C., Tokunaga, S., Zhou, H. and Cleveland, D.W. (2010) ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc. Natl Acad. Sci. USA, 107, 13318-13323.
19. Johnson, B.S., Snead, D., Lee, J.J., McCaffery, J.M., Shorter, J. and Gitler, A.D. (2009) TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem., 284, 20329-20339.
20. Kuo, P.H., Doudeva, L.G., Wang, Y.T., Shen, C.K. and Yuan, H.S. (2009) Structural insights into TDP-43 in nucleic-acid binding and domain interactions. Nucleic Acids Res., 37, 1799-1808.
21. Buratti, E., Dork, T., Zuccato, E., Pagani, F., Romano, M. and Baralle, F.E. (2001) Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J., 20, 1774-1784.
22. Polymenidou, M., Lagier-Tourenne, C., Hutt, K.R., Huelga, S.C., Moran, J., Liang, T.Y., Ling, S.C., Sun, E., Wancewicz, E., Mazur, C. et al. (2011) Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci., 14, 459-468.
23. Tollervey, J.R., Curk, T., Rogelj, B., Briese, M., Cereda, M., Kayikci, M., Konig, J., Hortobagyi, T., Nishimura, A.L., Zupunski, V. et al. (2011) Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci., 14, 452-458.
24. Bartels, T., Choi, J.G. and Selkoe, D.J. (2011) alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature, 477, 107-110.
25. Leitner, A., Walzthoeni, T., Kahraman, A., Herzog, F., Rinner, O., Beck, M. and Aebersold, R. (2010) Probing native protein structures by chemical cross-linking, mass spectrometry, and bioinformatics. Mol. Cell Proteomics, 9, 1634-1649.
26. Canet-Aviles, R.M., Wilson, M.A., Miller, D.W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M.J., Ringe, D., Petsko, G.A. and Cookson, M.R. (2004) The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl Acad. Sci. USA, 101, 9103-9108.
27. Rapaport, D. and Neupert, W. (1999) Biogenesis of Tom40, core component of the TOM complex of mitochondria. J. Cell Biol., 146, 321-331.
28. Lo, K.W., Kan, H.M. and Pfister, K.K. (2006) Identification of a novel region of the cytoplasmic Dynein intermediate chain important for dimerization in the absence of the light chains. J. Biol. Chem., 281, 9552-9559.
29. Dettmer, U., Newman, A.J., Luth, E.S., Bartels, T. and Selkoe, D. (2013) In vivo cross-linking reveals principally oligomeric forms of alpha-synuclein and beta-synuclein in neurons and non-neural Cells. J. Biol. Chem., 288, 6371-6385.
30. Repici, M., Straatman, K.R., Balduccio, N., Enguita, F.J., Outeiro, T.F. and Giorgini, F. (2012) Parkinson's disease-associated mutations in DJ-1 modulate its dimerization in living cells. J. Mol. Med. (Berl). [Epub ahead of print].
31. Deeg, S., Gralle, M., Sroka, K., Bahr, M., Wouters, F.S. and Kermer, P. (2010) BAG1 restores formation of functional DJ-1 L166P dimers and DJ-1 chaperone activity. J. Cell Biol., 188, 505-513.
32. Elden, A.C., Kim, H.J., Hart, M.P., Chen-Plotkin, A.S., Johnson, B.S., Fang, X., Armakola, M., Geser, F., Greene, R., Lu, M.M. et al. (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature, 466, 1069-1075.
33. Fiesel, F.C., Voigt, A., Weber, S.S., Van den Haute, C., Waldenmaier, A., Gorner, K., Walter, M., Anderson, M.L., Kern, J.V., Rasse, T.M. et al. (2010) Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. EMBO J., 29, 209-221.
34. Barmada, S.J., Skibinski, G., Korb, E., Rao, E.J., Wu, J.Y. and Finkbeiner, S. (2010) Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J. Neurosci., 30, 639-649.
35. Chang, C.K., Wu, T.H., Wu, C.Y., Chiang, M.H., Toh, E.K., Hsu, Y.C., Lin, K.F., Liao, Y.H., Huang, T.H. and Huang, J.J. (2012) The N-terminus of TDP-43 promotes its oligomerization and enhances DNA binding affinity. Biochem. Biophys. Res. Commun., 425, 219-224.
36. Cohen, T.J., Lee, V.M. and Trojanowski, J.Q. (2011) TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol. Med., 17, 659-667.
37. Polymenidou, M. and Cleveland, D.W. (2011) The seeds of neurodegeneration: prion-like spreading in ALS. Cell, 147, 498-508.
38. Fauvet, B., Mbefo, M.K., Fares, M.B., Desobry, C., Michael, S., Ardah, M.T., Tsika, E., Coune, P., Prudent, M., Lion, N. et al. (2012) alpha-synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer. J. Biol. Chem., 287, 15345-15364.
39. Nowak, D.E., Tian, B. and Brasier, A.R. (2005) Two-step cross-linking method for identification of NF-kappaB gene network by chromatin immunoprecipitation. Biotechniques, 39, 715-725.
40. Ramadoss, P., Unger-Smith, N.E., Lam, F.S. and Hollenberg, A.N. (2009) STAT3 targets the regulatory regions of gluconeogenic genes in vivo. Mol. Endocrinol., 23, 827-837.
41. Chen, H., Kluz, T., Zhang, R. and Costa, M. (2010) Hypoxia and nickel inhibit histone demethylase JMJD1A and repress Spry2 expression in human bronchial epithelial BEAS-2B cells. Carcinogenesis, 31, 2136-2144.
42. Gillespie, R.F. and Gudas, L.J. (2007) Retinoid regulated association of transcriptional co-regulators and the polycomb group protein SUZ12 with the retinoic acid response elements of Hoxa1, RARbeta(2), and Cyp26A1 in F9 embryonal carcinoma cells. J. Mol. Biol., 372, 298-316.
43. Pagani, F., Buratti, E., Stuani, C., Romano, M., Zuccato, E., Niksic, M., Giglio, L., Faraguna, D. and Baralle, F.E. (2000) Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element. J. Biol. Chem., 275, 21041-21047.
44. Gass, J., Lee, W.C., Cook, C., Finch, N., Stetler, C., Jansen-West, K., Lewis, J., Link, C.D., Rademakers, R., Nykjaer, A. et al. (2012) Progranulin regulates neuronal outgrowth independent of Sortilin. Mol. Neurodegener., 7, 33.